RY 144.17 -0.805% TD 77.455 -0.635% SHOP 78.32 -1.6451% CNR 173.65 0.2656% ENB 50.22 0.3597% CP 111.0 -0.6% BMO 128.99 -0.4937% TRI 236.04 1.4266% CNQ 105.42 0.4957% BN 60.93 0.6608% ATD 76.06 0.862% CSU 3709.0601 0.3808% BNS 66.06 0.2276% CM 66.92 -0.4759% SU 56.15 2.8954% TRP 53.465 0.9726% NGT 60.17 0.9564% WCN 225.82 -0.9561% MFC 36.01 -0.9081% BCE 46.315 -0.9517%

Eastwood Bio-Medical Canada Inc

Consumer Defensive CA EBM

0.55CAD
-(-%)

Last update at 2024-05-17T13:30:00Z

Day Range

0.550.55
LowHigh

52 Week Range

0.501.15
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Income before tax -0.14988M -0.60359M -0.85243M -0.57733M -0.86198M
Minority interest - - - - -
Net income -0.14988M -0.60359M -0.85243M -0.57733M -0.86198M
Selling general administrative 0.93M 0.97M 1.09M 1.08M 0.90M
Selling and marketing expenses - - - - -
Gross profit 0.90M 0.46M 0.21M 0.57M 0.38M
Reconciled depreciation 0.11M 0.11M 0.11M 0.05M 0.03M
Ebit -0.11175M -0.56968M -0.95647M -0.51513M -0.54781M
Ebitda -0.03232M -0.49055M -0.87816M -0.53124M -0.54032M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -0.12934M -0.59585M -0.98391M -0.57723M -0.56593M
Other operating expenses - - - - -
Interest expense 0.01M 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - 0.00000M 0.00137M 0.02M 0.08M
Net interest income -0.01070M -0.00279M -0.00101M 0.01M 0.08M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - 0.00000M
Total revenue 1.30M 0.98M 0.72M 1.29M 0.74M
Total operating expenses 1.43M 1.58M 1.70M 1.87M 1.31M
Cost of revenue 0.40M 0.52M 0.51M 0.73M 0.36M
Total other income expense net -0.00983M -0.00496M 0.13M -0.01119M -0.37317M
Discontinued operations - - - - -
Net income from continuing ops -0.14988M -0.60359M -0.85243M -0.57733M -0.86198M
Net income applicable to common shares -0.14988M -0.60359M -0.85243M -0.57733M -0.86198M
Preferred stock and other adjustments - - - - -
Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Total assets 0.58M 0.69M 0.93M 1.65M 2.25M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - 0.08M -
Total liab 0.88M 0.84M 0.47M 0.34M 0.36M
Total stockholder equity -0.29420M -0.14432M 0.46M 1.31M 1.89M
Deferred long term liab - - - - -
Other current liab 0.04M 0.10M 0.39M 0.00738M 0.01M
Common stock 4.69M 4.69M 4.69M 4.69M 4.69M
Capital stock 4.69M 4.69M 4.69M 4.69M 4.69M
Retained earnings -4.99109M -4.84121M -4.23762M -3.38518M -2.80785M
Other liab - - - - -
Good will - - - - -
Other assets 0.04M 0.08M 0.11M 0.40M -
Cash 0.04M 0.02M 0.12M 0.63M 0.83M
Cash and equivalents - - - - -
Total current liabilities 0.84M 0.80M 0.45M 0.34M 0.36M
Current deferred revenue - - - - -
Net debt 0.02M 0.01M - - -
Short term debt - - - - -
Short long term debt 0.03M - - - -
Short long term debt total - - - - -
Other stockholder equity 0.00951M 0.00951M 0.00951M 0.00951M 0.00951M
Property plant equipment 0.45M 0.55M 0.65M 0.46M 0.26M
Total current assets 0.10M 0.06M 0.17M 0.79M 1.99M
Long term investments - - - - -
Net tangible assets -0.29420M -0.14432M 0.46M 1.31M 1.89M
Short term investments - - - - -
Net receivables 0.01M 0.00602M 0.00970M 0.08M 1.16M
Long term debt 0.03M 0.03M 0.02M - -
Inventory - - - - -
Accounts payable 0.78M 0.71M 0.06M 0.33M 0.32M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 0.86M 0.26M
Deferred long term asset charges - - - - -
Non current assets total 0.48M 0.63M 0.76M 0.86M 0.26M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Investments -0.00300M -0.00557M 0.00000M -0.02311M 0.01000M
Change to liabilities 0.00777M 0.01M 0.02M 0.00249M 0.01M
Total cashflows from investing activities -0.00300M -0.00557M -0.00557M -0.02311M -0.02311M
Net borrowings 0.03M 0.02M 0.04M 0.04M 0.01000M
Total cash from financing activities 0.03M 0.02M 0.04M 0.04M 0.01000M
Change to operating activities 0.03M 0.38M 0.13M 0.11M 0.36M
Net income -0.14988M -0.60359M -0.85243M -0.57733M -0.86198M
Change in cash 0.02M -0.10179M -0.50269M -0.20124M -0.44479M
Begin period cash flow 0.02M 0.12M 0.63M 0.83M 1.27M
End period cash flow 0.04M 0.02M 0.12M 0.63M 0.83M
Total cash from operating activities -0.00429M -0.11621M -0.54269M -0.17813M -0.45479M
Issuance of capital stock - - - - 0.00000M
Depreciation 0.11M 0.11M 0.11M 0.05M 0.03M
Other cashflows from investing activities - - - - 0.01000M
Dividends paid - - - - -
Change to inventory - - - - 0.00000M
Change to account receivables -0.00857M 0.00367M 0.07M 0.15M -0.30612M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome 0.00463M -0.01186M -0.01679M 0.10M 0.31M
Capital expenditures 0.00300M 0.00557M 0.00557M 0.02M 0.02M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.03M 0.39M 0.18M 0.26M 0.07M
Stock based compensation - - - - -
Other non cash items 0.00340M -0.01186M 0.02M 0.10M 0.31M
Free cash flow -0.00730M -0.12179M -0.54269M -0.20124M -0.45479M

Fundamentals

  • Previous Close 0.55
  • Market Cap41.33M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.34728M
  • Revenue TTM1.12M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM 0.90M
  • Diluted EPS TTM-

Peer Comparison

Sector: Consumer Defensive Industry: Food Distribution

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EBM
Eastwood Bio-Medical Canada Inc
- -% 0.55 - - 36.91 2942.82 36.92 -147.6678
OGO
Organto Foods Incorporated
0.005 6.67% 0.08 - - 0.10 274.94 0.45 -1.4421

Reports Covered

Stock Research & News

Profile

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada. Eastwood Bio-Medical Canada Inc. operates as a subsidiary of Eastwood Bio-Medical Research Inc.

Eastwood Bio-Medical Canada Inc

4871 Shell Road, Richmond, BC, Canada, V6X 3Z6

Key Executives

Name Title Year Born
Dr. Youngsoo Kim CEO & Director NA
Ms. Yunji Kim Esq. Pres, CFO, Corp. Sec. & Director 1982

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).